Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)

7 Feb 2025 2:15 p.m. 2:45 p.m.
RajivAgarwal Oral Abstract Presenter United States